New Mammographic Techniques Versus MRI in Assessment of Breast Lesions
NCT ID: NCT06089148
Last Updated: 2023-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2015-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Value of Digital Breast Tomosynthesis in Breast Lesions
NCT06687902
Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography
NCT07145892
Abbreviated Breast MRI in Cancer Detection
NCT03870659
Non-mass Enhancement in Breast MRI
NCT04083027
Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
NCT06970288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
contrast enhanced mammography, tomosynthesis and MRI
CEDM and tomosynthesis versus MRI
contrast enhanced digital mammography, tomosyntheis and MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
contrast enhanced digital mammography, tomosyntheis and MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical indication for MRI breast imaging.
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa A Haggag
DR (lectureur)
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
141014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.